These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 16213320)
1. Relationship of posttransplantation erythrocytosis to hypercalcemia in renal transplant recipients. Akcay A; Kanbay M; Huddam B; Usluogullari CA; Arat Z; Ozdemir FN; Haberal M Transplant Proc; 2005 Sep; 37(7):3103-5. PubMed ID: 16213320 [TBL] [Abstract][Full Text] [Related]
2. Factors predisposing to post-renal transplant erythrocytosis. A prospective matched-pair control study. Kessler M; Hestin D; Mayeux D; Mertes PM; Renoult E Clin Nephrol; 1996 Feb; 45(2):83-9. PubMed ID: 8846535 [TBL] [Abstract][Full Text] [Related]
3. Persistent hypercalcemia is a significant risk factor for graft dysfunction in renal transplantation recipients. Ozdemir FN; Afsar B; Akgul A; Usluoğullari C; Akçay A; Haberal M Transplant Proc; 2006 Mar; 38(2):480-2. PubMed ID: 16549153 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin converting enzyme gene polymorphism and development of post-transplant erythrocytosis. Yildiz A; Yazici H; Cine N; Kazancioglu R; Akkaya V; Sever MS; Ark E; Erginel-Unaltuna N J Nephrol; 2003; 16(3):399-403. PubMed ID: 12832741 [TBL] [Abstract][Full Text] [Related]
5. Post transplant erythrocytosis in hypercalcemic renal transplant recipients. Kurella M; Butterly DW; Smith SR Am J Transplant; 2003 Jul; 3(7):873-7. PubMed ID: 12814479 [TBL] [Abstract][Full Text] [Related]
6. Erythropoiesis after kidney transplantation: the role of erythropoietin, burst promoting activity and early erythroid progenitor cells. Lezaic V; Biljanovic-Paunovic L; Pavlovic-Kentera V; Djukanovic L Eur J Med Res; 2001 Jan; 6(1):27-32. PubMed ID: 11313188 [TBL] [Abstract][Full Text] [Related]
7. Factors predisposing to post-renal transplant erythrocytosis: a retrospective study. Charfeddine K; Zaghdane S; Yaich S; Hakim A; Hachicha J Saudi J Kidney Dis Transpl; 2008 May; 19(3):371-7. PubMed ID: 18445895 [TBL] [Abstract][Full Text] [Related]
8. Risk factors of erythrocytosis post renal transplantation. Razeghi E; Kaboli A; Pezeshki ML; Meysamie AP; Khatami MR; Khashayar P Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):559-63. PubMed ID: 18580013 [TBL] [Abstract][Full Text] [Related]
9. Posttransplant erythrocytosis in renal transplant recipients at Jeddah Kidney Center, Kingdom of Saudi Arabia. Basri N; Gendo MZ; Haider R; Abdullah KA; Hassan A; Shaheen FA Exp Clin Transplant; 2007 Jun; 5(1):607-9. PubMed ID: 17617052 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of losartan in treatment of hyperuricemia and posttransplantation erythrocytosis: results of a prospective, open, randomized, case-control study. Zhu X; Chen J; Han F; Cheng M; Xu L; Zhang L; Ding X; Le Y Transplant Proc; 2009 Nov; 41(9):3736-42. PubMed ID: 19917377 [TBL] [Abstract][Full Text] [Related]
19. Serum stem cell factor level in renal transplant recipients with posttransplant erythrocytosis. Kiykim AA; Genctoy G; Horoz M; Tiftik NE; Gok E; Altun B; Arici M; Haznedaroglu I Artif Organs; 2009 Dec; 33(12):1086-90. PubMed ID: 19958348 [TBL] [Abstract][Full Text] [Related]
20. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation. Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]